BR100 Decreased By (-0.08%)
BR30 Increased By (0.08%)
KSE100 Decreased By (-0.11%)
KSE30 Decreased By (-0.2%)
AGHA 7.53 Decreased By ▼ -0.10 (-1.31%)
BECO 5.11 Decreased By ▼ -0.46 (-8.26%)
BML 58.30 Decreased By ▼ -1.44 (-2.41%)
BOP 34.58 Increased By ▲ 0.18 (0.52%)
CNERGY 13.68 Increased By ▲ 0.57 (4.35%)
CSIL 6.30 Decreased By ▼ -0.11 (-1.72%)
FCCL 57.55 Decreased By ▼ -0.51 (-0.88%)
FFL 16.50 Increased By ▲ 0.27 (1.66%)
FNEL 1.20 Decreased By ▼ -0.01 (-0.83%)
KEL 7.36 Decreased By ▼ -0.07 (-0.94%)
KOSM 5.98 Decreased By ▼ -0.05 (-0.83%)
LOTCHEM 27.51 Decreased By ▼ -0.16 (-0.58%)
MLCF 101.93 Decreased By ▼ -0.82 (-0.8%)
NBP 203.29 Decreased By ▼ -1.77 (-0.86%)
NCPL 60.47 Increased By ▲ 0.84 (1.41%)
NPL 69.80 Increased By ▲ 1.24 (1.81%)
OGDC 318.48 Decreased By ▼ -0.44 (-0.14%)
PACE 11.12 Increased By ▲ 0.07 (0.63%)
PAEL 42.86 Decreased By ▼ -0.24 (-0.56%)
PIBTL 16.72 Increased By ▲ 0.09 (0.54%)
PPL 230.62 Increased By ▲ 1.17 (0.51%)
PRL 76.73 Increased By ▲ 5.93 (8.38%)
PTC 71.18 Increased By ▲ 0.18 (0.25%)
SSGC 27.10 Decreased By ▼ -0.31 (-1.13%)
TBL 10.28 Decreased By ▼ -0.03 (-0.29%)
TELE 8.56 Increased By ▲ 0.03 (0.35%)
TPL 23.59 Increased By ▲ 0.53 (2.3%)
TPLP 15.45 Decreased By ▼ -0.31 (-1.97%)
TREET 24.51 Decreased By ▼ -0.20 (-0.81%)
TRG 60.09 Decreased By ▼ -0.20 (-0.33%)

ISLAMABAD: The Federal Board of Revenue (FBR) has conveyed to the pharmaceutical industry that the medicines not registered under the Drugs Act 1976 are chargeable to the standard rate of 17 percent sale tax.

Moreover, the FBR further declared that only drugs registered under the Drugs Act, 1976 are entitled to the reduced rate of one percent sales tax and no exemption/ reduced rate is available to any other drugs.

The FBR on Wednesday issued a clarification to the pharmaceutical manufacturers to clarify important issues of the industry.

The industry questioned what rate of tax should be charged from unregistered persons as most of the retailers/ distributors are un-registered. (1%+ 3% further tax).

The FBR responded that as per Sr. No 81 of Table-I of the Eighth Schedule to Sales Tax Act, 1990 manufacture or import of substances registered as drugs under the Drugs Act, 1976 shall charge sales tax @1 percent.

This is subject to the conditions that: (i) Tax charged and deposited by the manufacturer or importer, as the case may be, shall be final discharge of tax in the supply chain (ii) No input tax shall be adjusted by the manufacturer or importer.

Moreover, as per section 3(1A) of the said Act further tax @ 3% shall be charged, levied and paid where taxable supplies are made to a person who has not obtained a registration number, or he is not an active taxpayer.

The industry has raised a question that the tax has been imposed on drugs manufactured and registered under The Drugs Act, 1976 so what will be the rate of sales tax on drugs registered under DRAP ACT, 2012.

The FBR responded that as per Sr. No 81 of table-I of the Eighth Schedule to Sales Tax Act, 1990 reduced rate of sales tax @1% is available subject to conditions that: (i) Tax charged and deposited by the manufacturer or importer, as the case may be, shall be final discharge of tax in the supply chain (ii) No input tax shall be adjusted by the manufacturer or importer. It is clarified that only drugs registered under the Drugs Act, 1976 are entitled to reduced rate of 1% whereas no exemption/ reduced rate is available to any other drugs.

The industry asked the FBR to clarify if the medicines not covered under the Drugs Act 1976 are still exempt?

The FBR responded that the medicines not registered under the Drugs Act 1976 are chargeable to a standard rate of sale tax @17% and all applicable provisions of Sales Tax Act, 1990 will also apply, accordingly.

Copyright Business Recorder, 2022

Comments

Comments are closed for this article.